DK1814555T3 - S-mirtazapin til behandling af hedeture - Google Patents

S-mirtazapin til behandling af hedeture

Info

Publication number
DK1814555T3
DK1814555T3 DK05808013T DK05808013T DK1814555T3 DK 1814555 T3 DK1814555 T3 DK 1814555T3 DK 05808013 T DK05808013 T DK 05808013T DK 05808013 T DK05808013 T DK 05808013T DK 1814555 T3 DK1814555 T3 DK 1814555T3
Authority
DK
Denmark
Prior art keywords
mirtazapine
treatment
hot flushes
flushes
hot
Prior art date
Application number
DK05808013T
Other languages
Danish (da)
English (en)
Inventor
B W M M Bernardus Peeters
Anton Egbert Peter Adang
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1814555(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of DK1814555T3 publication Critical patent/DK1814555T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK05808013T 2004-11-15 2005-11-14 S-mirtazapin til behandling af hedeture DK1814555T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105778 2004-11-15
PCT/EP2005/055947 WO2006051111A1 (fr) 2004-11-15 2005-11-14 S-mirtazapine pour le traitement des bouffées de chaleur

Publications (1)

Publication Number Publication Date
DK1814555T3 true DK1814555T3 (da) 2009-12-07

Family

ID=34929859

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05808013T DK1814555T3 (da) 2004-11-15 2005-11-14 S-mirtazapin til behandling af hedeture

Country Status (31)

Country Link
US (4) US20070265245A1 (fr)
EP (1) EP1814555B1 (fr)
JP (1) JP2008519810A (fr)
KR (1) KR20070085470A (fr)
CN (2) CN102772414A (fr)
AR (1) AR053780A1 (fr)
AT (1) ATE439843T1 (fr)
AU (1) AU2005303778B2 (fr)
BR (1) BRPI0517818A2 (fr)
CA (1) CA2587283C (fr)
CY (1) CY1110538T1 (fr)
DE (1) DE602005016141D1 (fr)
DK (1) DK1814555T3 (fr)
ES (1) ES2329815T3 (fr)
HK (1) HK1104235A1 (fr)
HR (1) HRP20090513T1 (fr)
IL (1) IL182767A (fr)
MX (1) MX2007005827A (fr)
MY (1) MY144089A (fr)
NO (1) NO20072285L (fr)
NZ (1) NZ554858A (fr)
PE (1) PE20061051A1 (fr)
PL (1) PL1814555T3 (fr)
PT (1) PT1814555E (fr)
RS (1) RS51138B (fr)
RU (1) RU2396957C2 (fr)
SI (1) SI1814555T1 (fr)
TW (1) TW200631584A (fr)
UA (1) UA88655C2 (fr)
WO (1) WO2006051111A1 (fr)
ZA (1) ZA200703884B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1898919A2 (fr) * 2005-06-27 2008-03-19 N.V. Organon Procede de traitement de symptomes vasomoteurs induits par la depletion hormonale
US20070129611A1 (en) * 2005-12-06 2007-06-07 University Of North Texas Health Science Center At Fort Worth System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
EP1993556A1 (fr) * 2006-03-06 2008-11-26 N.V. Organon Méthode perfectionnée pour sevrer d'un traitement hormonal de symptômes vasomoteurs induits par un épuisement hormonal
CA2669833A1 (fr) * 2006-11-22 2008-05-29 N.V. Organon Systeme de liberation vaginale de mirtazapine
US7645750B2 (en) 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2009018992A (ja) 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8420624B2 (en) 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
JP6876003B2 (ja) 2015-02-27 2021-05-26 デクラ リミテッド イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置
BR112019024802A2 (pt) * 2017-05-25 2020-07-21 Glytech Llc. terapia combinada para transtornos neuropsiquiátricos responsivos ao antagonista de nmdar

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) * 1997-09-12 1999-03-30 Mitsubishi Electric Corp 半導体装置
DK1067934T3 (da) * 1998-04-02 2004-03-29 Akzo Nobel Nv Flydende oral opløsning omfattende det anti-depressive middel mirtazapin

Also Published As

Publication number Publication date
CN101056641A (zh) 2007-10-17
MY144089A (en) 2011-08-15
US20070265245A1 (en) 2007-11-15
ZA200703884B (en) 2009-07-29
CA2587283A1 (fr) 2006-05-18
US20100267694A1 (en) 2010-10-21
KR20070085470A (ko) 2007-08-27
US20130225559A1 (en) 2013-08-29
CN102772414A (zh) 2012-11-14
JP2008519810A (ja) 2008-06-12
RU2396957C2 (ru) 2010-08-20
TW200631584A (en) 2006-09-16
HK1104235A1 (en) 2008-01-11
EP1814555B1 (fr) 2009-08-19
IL182767A (en) 2011-07-31
RS51138B (sr) 2010-10-31
US20120302552A1 (en) 2012-11-29
CA2587283C (fr) 2013-01-15
DE602005016141D1 (de) 2009-10-01
IL182767A0 (en) 2007-09-20
ATE439843T1 (de) 2009-09-15
PL1814555T3 (pl) 2010-01-29
SI1814555T1 (sl) 2009-12-31
AU2005303778B2 (en) 2011-02-17
PT1814555E (pt) 2009-09-30
AR053780A1 (es) 2007-05-23
PE20061051A1 (es) 2006-10-26
EP1814555A1 (fr) 2007-08-08
HRP20090513T1 (en) 2009-10-31
UA88655C2 (ru) 2009-11-10
WO2006051111A1 (fr) 2006-05-18
RU2007122391A (ru) 2008-12-20
MX2007005827A (es) 2007-07-20
NO20072285L (no) 2007-06-13
NZ554858A (en) 2009-10-30
AU2005303778A1 (en) 2006-05-18
BRPI0517818A2 (pt) 2010-03-16
ES2329815T3 (es) 2009-12-01
CY1110538T1 (el) 2015-04-29

Similar Documents

Publication Publication Date Title
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK1720571T3 (da) Fremgangsmåde til behandling af hæmolytisk sygdom
DK1948176T3 (da) Diarylurinstoffer til behandling af pulmonær hypertension
DK1708992T3 (da) Sulfonamidderivater til behandling af sygdomme
DK1830843T3 (da) Indolidon-derivater til behandling eller forebyggelse af fibrotiske sygdomme
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK1720866T3 (da) Fremgangsmåde
DK1877232T3 (da) Fremgangsmåde til behandling af træoverflader
DK1737461T3 (da) Carbolin-derivater til inhibering af angiogenese
DK1748077T3 (da) Fremgangsmåde til fremstilling af protein
DK1888033T3 (da) Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
DK1814555T3 (da) S-mirtazapin til behandling af hedeture
DK1630309T3 (da) Afløb
DK1801108T3 (da) Morpholinforbindelser til behandling af inflammationer.
DK1709082T3 (da) Sammensætning til behandling af patologi knyttet til MSRV/HERV-W
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK3326681T3 (da) Indretning til behandling af analsphincteren
DK1881830T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet
DK3332789T3 (da) Cladribinkur til behandling af multipel sklerose
DK1789529T3 (da) Fremgangsmåde til forbedring af konserveringen af lactococcus
DK1812002T3 (da) Behandling af mastitis